ATLASTrevi Therapeutics (TRVI) earnings date: Nov 12, 2026
Trevi Therapeutics (TRVI) reports earnings for the quarter ended Sep 30, 2026 on Thu, Nov 12, 2026, after the close. Analysts expect EPS of -$0.13.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on TRVI
| Last price | $13.32 (-1.8%) |
|---|---|
| Normal 1-day range (±1σ) | ±3.3% |
| Earnings beat history | Beat the EPS estimate in 1 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Trevi Therapeutics stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Trevi Therapeutics reports on Nov 12, 2026. One email the day before, with ATLAS’s read on Trevi Therapeutics. You can switch it off at any time.
Alert me before TRVI reportsFree to start. Creating an account takes under a minute.
Notify me when Trevi Therapeutics reports
Track TRVI free Add Trevi Therapeutics to a free ATLAS watchlist and see its next report date in one place.
TRVI earnings at a glance
| Next report (confirmed) | Thu, Nov 12, 2026 |
|---|---|
| Time | After the close |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.13 |
| Last report | Aug 6, 2026 · In line |
| Beat rate (last 5 reports) | 1 of 5 (20%) |
| Average EPS surprise | -5.4% |
| Average move around a report | ±2.3% (last 5) |
| Sector | Healthcare · Biotechnology |
Trevi Therapeutics earnings history: last 5 reports
Trevi Therapeutics last reported on Aug 6, 2026: EPS of -$0.11 against an estimate of -$0.11 (0.0% surprise), in line with the estimate.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 6, 2026 | -$0.11 | -$0.11 | 0.0% | In line | -0.8% |
| Jul 15, 2026 | $3.14 | $2.81 | -10.5% | Miss | -3.1% |
| Jun 24, 2026 | -$0.02 | -$0.02 | 0.0% | In line | +3.6% |
| May 5, 2026 | -$0.07 | -$0.09 | -28.6% | Miss | -0.8% |
| Mar 31, 2026 | $0.59 | $0.66 | +11.9% | Beat | +3.5% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for TRVI
See the fair value, the probability range and the earnings history of Trevi Therapeutics on its ATLAS page.
Trevi Therapeutics (TRVI) stock analysisPlans from €3.99 a month.
Trevi Therapeutics earnings: frequently asked questions
When does Trevi Therapeutics (TRVI) report earnings?
Trevi Therapeutics is scheduled to report on Thursday, November 12, 2026, after the close. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for TRVI?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.13 per share (USD). Estimates can change before the report.
How often does TRVI beat earnings estimates?
Of its last 5 reports with a recorded result, Trevi Therapeutics beat the EPS estimate 1 times; the average surprise was -5.4%. Past results do not predict the next one.
How much does TRVI move around earnings?
Over its last 5 reports the stock moved an average of 2.3% (absolute, from the close before the report day to the close after it), and finished higher 2 of 5 times.
Did Trevi Therapeutics beat earnings estimates last quarter?
Trevi Therapeutics last reported on Aug 6, 2026: EPS of -$0.11 against an estimate of -$0.11 (0.0% surprise), in line with the estimate.
How much does TRVI usually move in a day?
On a normal trading day the ATLAS model puts TRVI’s one-day range at about ±3.3%, with a 50% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Thu, Nov 12, 2026
Educational information, not investment advice. Disclaimer